Results for tag: "Peripheral Thrombus Management"

The Peripheral Thrombus Management market within the Cardiovascular Devices sector is focused on the development of devices and therapies to treat peripheral artery disease (PAD). This includes the use of catheters, stents, and other devices to remove blockages in the arteries, as well as the use of drugs to reduce the risk of clotting. These treatments are used to improve blood flow and reduce the risk of stroke, heart attack, and other cardiovascular events. The market is driven by the increasing prevalence of PAD, as well as the development of new technologies and treatments. Additionally, the rising demand for minimally invasive treatments and the increasing awareness of the importance of early diagnosis and treatment of PAD are also contributing to the growth of the market. Some of the major companies in the Peripheral Thrombus Management market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, and B. Braun Melsungen AG. Show Less Read more